Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Thermo Fisher Scientific Acquires Micro-Volume UV-Vis Instrumentation

By HospiMedica staff writers
Posted on 29 Oct 2007
Thermo Fisher Scientific, Inc. More...
(Waltham, MA, USA) has acquired NanoDrop Technologies, LLC (Wilmington, DE, USA), a manufacturer of microvolume ultraviolet visible (UV-Vis) instrumentation.

The acquisition will strengthen Thermo Fisher's range of UV-Vis spectrophotometry instruments for applications involving small sample volumes. For example, micro-volume samples are used in emerging life sciences research that involves measurement of DNA and proteins. NanoDrop, has annual revenues of approximately US$35 million.

"Growing demand from our laboratory customers to accelerate sample preparation time is now compounded by the need to work with smaller sample sizes,” said Marijn E. Dekkers, president and CEO of Thermo Fisher Scientific. "NanoDrop's patented technologies uniquely allow customers to quickly and easily analyze difficult microvolume samples without the need for dilution. This preserves precious samples to greatly increase laboratory productivity.”

NanoDrop currently produces three products--the NanoDrop ND-1000 and ND-8000 UV-Vis spectrophotometers and the NanoDrop ND-3300 fluorescence spectrophotometer. The ND-1000 is a full-spectrum UV-Vis spectrophotometer used to quantify nucleic acids, proteins, fluorescent dyes, and other compounds. The ND-8000 is also a full-spectrum UV-Vis spectrophotometer that can measure eight samples at a time, permitting measurement of 96 samples in five minutes. The ND-3300 is a versatile fluorometer with broad excitation range that enables the use of microreactions for quantitation of limited mass. These instruments are highly versatile tools that are suitable for a wide variety of laboratories and uses, including life-sciences research and industrial applications.

The NanoDrop product line will be integrated into Thermo Fisher's scientific instruments business, part of its Analytical Technologies Segment, and will be marketed under the company's Thermo Scientific technology brand.


Related Links:
Thermo Fisher Scientific Inc
NanoDrop Technologies

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.